
WASHINGTON — Vaccine manufacturer Moderna said Wednesday the US Food and Drug Administration (FDA) had approved its new influenza vaccine, nearly six months after the regulator briefly rejected an application for review. The company’s…
View original source — Philippine Daily Inquirer ↗



